EurekAlert! -
15 Nov 2017 07:00
(Massachusetts General Hospital) A team of Massachusetts General Hospital researchers has developed a manganese-based magnetic resonance imaging contrast agent, a potential alternative to gadolinium-based agents, which carry significant health risks for some patients
Share this Article